His research project came out on top in tough competition with other leading young European researchers.
This funding, called the Starting Grant, is being awarded for the first time by the newly-established research funding body, the European Research Council (ERC). The aim of the ERC is to promote scientific excellence in Europe by supporting the best researchers with relatively large research grants. Only a small percentage of nearly 10 000 researchers who submitted an application last spring was successful.
"This grant means that we are regarded as occupying the absolute cutting edge of European research in our field, and it is important for both the Sahlgrenska Academy and Göteborg University. For me personally the grant means that I can focus more closely on my research during the next five years and expand my research team," says Associate Professor Martin Bergö.
Martin Bergö is studying two different diseases: cancer and accelerated ageing (progeria). Cancer is a common disease whilst progeria is a rare genetic disease. Children with progeria are born normal but show premature signs of ageing; they stop growing, lose their hair and develop cardiovascular diseases. They seldom survive beyond the age of 16. At present there is no treatment, but Martin Bergö has, together with a research team in the USA, identified a new treatment strategy which is currently being tested on children with progeria. The research has also provided a new genetic method of studying the underlying mechanisms and the treatment of cancer."My vision is that the research will lead to a better understanding of the causes of cancer and progeria and to find new treatments. We also hope that our studies into progeria will provide us with new information about the factors that govern normal ageing," adds Martin Bergö.
What is the link between cancer and progeria? Both diseases are caused by mutations in what is known as a CAAX protein. Martin Bergö's research has gone a step further and shown that both diseases can be treated with the same type of drug. The CAAX proteins that cause progeria and cancer are transported to a variety of intracellular locations. The transport of CAAX proteins is regulated by a number of enzymes. Martin Bergö is testing the hypothesis that cancer and progeria can be treated by using drugs that block some of these enzymes. The aim of treatment is to prevent the mutated CAAX proteins being transported to the locations within the cell where they cause damage.
To test this hypothesis, the research team has developed genetically modified mice that develop progeria and various forms of cancer. The unique aspect of the group's mouse models is that it is also possible to stop the production of the enzymes that govern the transport of the mutated CAAX proteins.
"When we stopped the production of one of the enzymes, the rate of tumour development dropped sharply in mice with cancer, and there are early indications that we can reduce the incidence of bone fractures which are common in mice with progeria. But even if our research suggests that drugs that block these enzymes can be effective future treatment for both diseases, there is much research left to do. Therefore, the money from the ERC is extremely welcome," says Martin Bergö.
Martin Bergö studied medicine in Umeå and defended his doctoral thesis in medical biochemistry in 1998. Following his doctorate he was recruited for postdoctoral training at the Gladstone Institute in San Francisco, USA, where he spent five very productive years. For the past 3 years Martin Bergö has lived in Kungsbacka outside Göteborg and has led a research team at the Wallenberg Laboratory, Sahlgrenska Academy at Göteborg University.For further information, please contact:
Pressofficer Ulrika Lundin; email@example.com; +46-70 775 88 51
Ulrika Lundin | idw
Classroom in Stuttgart with Li-Fi of Fraunhofer HHI opened
03.11.2017 | Fraunhofer-Institut für Nachrichtentechnik, Heinrich-Hertz-Institut, HHI
Starting school boosts development
11.05.2017 | Max-Planck-Institut für Bildungsforschung
DNA molecules that follow specific instructions could offer more precise molecular control of synthetic chemical systems, a discovery that opens the door for engineers to create molecular machines with new and complex behaviors.
Researchers have created chemical amplifiers and a chemical oscillator using a systematic method that has the potential to embed sophisticated circuit...
MPQ scientists achieve long storage times for photonic quantum bits which break the lower bound for direct teleportation in a global quantum network.
Concerning the development of quantum memories for the realization of global quantum networks, scientists of the Quantum Dynamics Division led by Professor...
Researchers have developed a water cloaking concept based on electromagnetic forces that could eliminate an object's wake, greatly reducing its drag while...
Tiny pores at a cell's entryway act as miniature bouncers, letting in some electrically charged atoms--ions--but blocking others. Operating as exquisitely sensitive filters, these "ion channels" play a critical role in biological functions such as muscle contraction and the firing of brain cells.
To rapidly transport the right ions through the cell membrane, the tiny channels rely on a complex interplay between the ions and surrounding molecules,...
The miniaturization of the current technology of storage media is hindered by fundamental limits of quantum mechanics. A new approach consists in using so-called spin-crossover molecules as the smallest possible storage unit. Similar to normal hard drives, these special molecules can save information via their magnetic state. A research team from Kiel University has now managed to successfully place a new class of spin-crossover molecules onto a surface and to improve the molecule’s storage capacity. The storage density of conventional hard drives could therefore theoretically be increased by more than one hundred fold. The study has been published in the scientific journal Nano Letters.
Over the past few years, the building blocks of storage media have gotten ever smaller. But further miniaturization of the current technology is hindered by...
11.12.2017 | Event News
08.12.2017 | Event News
07.12.2017 | Event News
15.12.2017 | Power and Electrical Engineering
15.12.2017 | Materials Sciences
15.12.2017 | Life Sciences